Aug. 1 at 2:26 AM
$STRO Jane needs to not be a hero. Preclinical molecules with no Phase 1 expansion data until 2027 - spread way too thin. Need to use her head, announce "strategic alternatives" and the stock goes to
$1.50 overnight. Stick a 250M asking price on it - go to
$PCVX or
$EXEL and try and sell the whole thing - they give you 180M-200M in current market, you say thanks and call it a day. Puts stock around 2-2.50/share. The dilution that will eventually be needed to do anything of value would be catastrophic. Know the hand you are holding. Trying to take 3 preclinical molecules into clinic with just 18-24 months of cash, your stock price at all time lows and a biotech market where trying to use meaningful capital will get you demolished? Literally would be insanity. Lets hope they are smarter than this dumb guy who can see this clearly and figure it out
